Overview

Sleeping Aids Market Introduction:

Global Sleeping Aids Market is estimated to value over USD 115 Billion by 2027 end and register a CAGR of over 6.5% during the forecast period 2020 to 2027.
Stressful lifestyles have reduced the amount of sleeping time an average person needs resulting in sleep disorders like insomnia, sleep apnea and mental disorders like depression and nervous breakdown. These are some of the crucial factors responsible for the significant growth of the sleep aids market globally.

Sleeping Aids Market Overview:
Product-wise, the market is bifurcated into insomnia treatment drugs, narcolepsy treatment drugs, devices and others. Insomnia treatment drugs segment is further fragmented into doxepin hydrochloride, eszopiclone, ramelteon, triazolam, quazepam and others.
The narcolepsy treatment drugs segment is further sub-segmented into Modafinil, sodium Oxybate, Armodafinil and others. The devices segment is sub-segmented into positive airway pressure device and it is further categorised as continuous positive airway pressure (CPAC) device, auto adjusting positive airway pressure (APAP) device and bi-level positive airway pressure (BiPAP) device. The others segment is further bifurcated into mattresses and pillows, chin straps and mouth pieces and nasal devices.

Depending on the indication, the market is categorised as insomnia, sleep deprivation, narcolepsy, sleep apnea and others. Narcolepsy segment is likely to grow at a high CAGR during the forecast period. The reason for this is that narcolepsy is found in 1 in 2000 people. It also causes loss of appetite and it creates difficulty in concentrating on work. Therefore, this segment is likely to show some positive market growth.

Sleeping Aids Market Regional Insight:
The sleeping aids market is anticipated to show substantial growth in the Asia Pacific region owing to the increasing prevalence of sleeping disorders, rise in the geriatric population in the region and surgical awareness regarding sleeping aids products.

Sleeping Aids Market

Sleeping Aids Market Segmentation:

By Product Type
• Insomnia Treatment Drugs
• Doxepin Hydrochloride
• Eszopiclone
• Ramelteon
• Triazolam
• Zaleplon
• Quazepam
• Others

By Narcolepsy Treatment Drugs
• Modafinil
• Sodium Oxybate
• Armodafinil
• Others

By Others
• Mattresses and Pillows
• Chin Straps
• Mouth Pieces and Nasal Devices

By Indication
• Insomnia
• Sleep Deprivation
• Narcolepsy
• Sleep Apnea
• Others

By Region
• North America
• Europe
• Asia Pacific
• Latin America

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

Key Market Players:
• Pfizer Inc.
• ResMed Inc.
• Merck & Co. Inc.
• GlaxoSmithKline Plc.
• Fisher and Paykel Healthcare
• EarlySense Ltd.
• SleepMed

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the global sleeping aids market by Product Type, By Narcolepsy Treatment Drugs, By Others, by Indication and by Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific and Latin America
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions